Advertisement

Annals of Surgical Oncology

, Volume 9, Issue 9, pp 840–846 | Cite as

Sentinel node biopsy in vulvar and vaginal melanoma: Presentation of six cases and a literature review

  • Liana Abramova
  • Jaysheree Parekh
  • William P. IrvinJr
  • Laurel W. Rice
  • Peyton T. TaylorJr
  • Willie A. Anderson
  • Craig L. SlingluffJrEmail author
Original Articles

Abstract

Background

Urogenital melanoma is a rare neoplasm with poor prognosis. Its management in the past involved radical vulvectomy and complete bilateral inguinofemoral lymphadenectomy. Sentinel lymph node biopsy is an accurate low-morbidity procedure when used in the context of cutaneous melanoma. However, prophylactic lymphadenectomy has not been shown to improve survival of melanoma patients. We wanted to determine the feasibility of sentinel lymph node biopsy in patients with female urogenital melanoma as a staging procedure.

Methods

Six patients with vulvar or vaginal melanomas underwent preoperative lymphatic mapping with99mTc-labeled sulfur colloid followed by sentinel lymphadenectomy. In addition, we reviewed the literature on the application of sentinel lymph node biopsy in urogenital tract melanomas.

Results

One or more sentinel nodes were identified in all six patients by lymphoscintigraphy. All patients underwent sentinel lymphadenectomy, except for one patient with a deep vaginal melanoma that drained to pelvic nodes. The five successful cases had unilateral drainage patterns. None of the sentinel lymph nodes excised had tumor invasion. Combined with five other patients from the published literature, the success rate of localizing sentinel lymph nodes in the patients with urogenital melanoma approaches 100%.

Conclusions

This experience, plus reports of a small number of patients from three similar studies, supports the impression that sentinel lymph node biopsy is feasible for vulvar and vaginal melanoma.

Key Words

Melanoma Sentinel lymph nodes Valvar Vaginal 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chung A, Casey M, Flannery J. Malignant melanoma of the vagina—report of 19 cases.Obstet Gynecol 1980;55:720–7.PubMedGoogle Scholar
  2. 2.
    Hacker NF. Vulvar cancer. In: Berek JS, Adashi EY, Hillard PA, eds.Novak's Gynecology. 12th ed. Baltimore: Williams & Wilkins, 1996:1231–59.Google Scholar
  3. 3.
    Weistock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival.Am J Obstet Gynecol 1994;171:1225–30.Google Scholar
  4. 4.
    Phillips GL, Bundy BN, Okagaki T, Krucera PR, Stehman FB. Malignant melanoma of vulva treated by radical hemivul vectomy: a prospective study of the Gynecologic Oncology Group.Cancer 1994;73:2626–32.CrossRefGoogle Scholar
  5. 5.
    Buchanan DJ, Schlaerth J, Kurosaki T. Primary vaginal melanoma: thirteen year disease free survival after wide local excision and review of recent literature.Am J Obstet Gynecol 1998;178:1177–84.PubMedCrossRefGoogle Scholar
  6. 6.
    Trimble EL. Melanoma of the vulva and vagina.Oncology 1996; 10:1017–23.PubMedGoogle Scholar
  7. 7.
    Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlof B, Ringborg UK. Malignant melanoma of vulva in a nationwide. 25 year study of 219 Swedish females: clinical observations and histopathologic features.Cancer 1999;86:1273–84.PubMedCrossRefGoogle Scholar
  8. 8.
    Reid G, Schmidt R, Roberts J, Hopkins M, Barett R, Morley G. Primary melanoma of the vagina: a clinicopathologic analysis.Obstet Gynecol 1989;74:190–9.PubMedGoogle Scholar
  9. 9.
    Beller U, Demopoulos RI, Beckman EM. Vulvovaginal melamoma: a clinicopathologic view.J Reprod Med 1986;31:315–9.PubMedGoogle Scholar
  10. 10.
    Jaramilo BA, Ganjei P, Averette HE, Seven BU, Lovecchio JL. Malignant melanoma of the vulva.Obstet Gynecol 1985;66:398–401.Google Scholar
  11. 11.
    Morton D, Wen D, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392–9.PubMedGoogle Scholar
  12. 12.
    Cabanas RM. An approach for the treatment of penile carcinoma.Cancer 1977;39:456–66.PubMedCrossRefGoogle Scholar
  13. 13.
    Ames SE, Krag DN, Brady MS. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases.J Surg Oncol 1998;67:251–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Guiliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer.J Clin Oncol 1997;15:2345–50.Google Scholar
  15. 15.
    Bilchik AJ, Giuliano A, Essner R, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.Cancer J Sci Am 1998;4:351–8.PubMedGoogle Scholar
  16. 16.
    Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer.Obstet Gynecol 1994;84:163–7.Google Scholar
  17. 17.
    Levenback C, Burke TW, Morris M, Malpica A, Lucas K, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer.Gynecol Oncol 1995;59:216–20.PubMedCrossRefGoogle Scholar
  18. 18.
    deHullu JA, Hollema H, Piers DA, et al. Sentinel lymph node biopsy is highly accurate in squamous cell carcinoma of the vulva.J Clin Oncol 2000;18:2811–6.Google Scholar
  19. 19.
    DeCesare SL, Fiorica JF, Roberts WS, et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer.Gynecol Oncol 1997;66:425–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Ansink AC, Sie-Go DM, van der Velden J, et al. Identification of sentinel nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study.Cancer 1999;86:652–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Levenback C. Introperative lymphatic mapping and sentinel node identification: gynecologic applications.Recent Results Cancer Res 2000;157:150–8.PubMedGoogle Scholar
  22. 22.
    Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva.Gynecol Oncol 2000;76:40–4.PubMedCrossRefGoogle Scholar
  23. 23.
    DeCicco CD, Sideri M, Bartolomei M, et al. Sentinel node biopsy in early vulvar cancer.Br J Cancer 2000;82:295–9.CrossRefGoogle Scholar
  24. 24.
    Irvin WP, Bliss AS, Rice LW, Taylor PT, Andersen WA. Malignant melanoma of the vagina and locoregional control: radical surgery revisited.Gynecol Oncol 1998;71:476–80.PubMedCrossRefGoogle Scholar
  25. 25.
    Levavi H, Sabah G, Levy T, et al. Sentine node in patients with vulvar cancer intraoperative identification and prognosis (abstract P.06.05).Eur J Nucl Med 1999;26(Suppl):S89.Google Scholar
  26. 26.
    Rodier JF, Routiot T, David E, Ott G, Schneegans O, Ghnassia JP. Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study.Oncol Rep 1999;6:1249–52.PubMedGoogle Scholar
  27. 27.
    Rodier JF, Janser JC, David E, Routiot T, Ott G. Radiopharmaceutical-guided surgery in primary malignant melanoma of the vagina.Gynecol Oncol 1999;75:308–9.PubMedCrossRefGoogle Scholar
  28. 28.
    DeMatos P, Tyler D, Seigler HF. Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center.Surgery 1998;124: 38–48.PubMedGoogle Scholar
  29. 29.
    Figge DC, Tamimi HK, Greer BE. Lymphatic spread in carcinoma of the vulva.Am J Obstet Gynecol 1985;152:387–94.PubMedGoogle Scholar
  30. 30.
    Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG. Management of regional lymph nodes and their prognostic influence in vulvar cancer.Obstet Gynecol 1983;61: 408–12.PubMedGoogle Scholar
  31. 31.
    White DC, Schuler FR, Pruitt SK, et al. Timing of sentinel lymph node mapping after lymphoscintigraphy.Surgery 1999;126:156–61.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc 2002

Authors and Affiliations

  • Liana Abramova
    • 1
  • Jaysheree Parekh
    • 2
  • William P. IrvinJr
    • 3
  • Laurel W. Rice
    • 3
  • Peyton T. TaylorJr
    • 3
  • Willie A. Anderson
    • 3
  • Craig L. SlingluffJr
    • 1
    Email author
  1. 1.Department of Surgery, Division of Surgical OncologyUniversity of Virginia Health Sciences CenterCharlottesville
  2. 2.Department of Radiology, Division of Nuclear MedicineUniversity of Virginia Health Sciences CenterCharlottesville
  3. 3.Department of Obstetrics and Gynecology, Division of Gynecologic OncologyUniversity of Virginia Health Sciences CenterCharlottesville

Personalised recommendations